TALS - Talaris Therapeutics EPS misses by $0.06 November, 12 2021 08:52 AM Talaris Therapeutics Inc. Talaris Therapeutics (NASDAQ:TALS): Q3 GAAP EPS of -$0.32 misses by $0.06. Cash, cash equivalents and marketable securities of $254.7M Press Release For further details see: Talaris Therapeutics EPS misses by $0.06